Clinical Trials

344 enrolled

BreastCNS

Brain Neoplasms, Breast Neoplasms, Triple Negative Breast Neoplasms

NCT01670500 2025-04-09

Cisplatin vs. Doxorubicin/Cyclophosphamide in BrCa

118 enrolled 23 charts

Phase 2 Active not recruiting

Breast Neoplasms

NCT02299999 2025-01-15

SAFIR02_Breast

1,460 enrolled

Breast Neoplasms

NCT01074970 2024-09-19

PARP Inhibition for Triple Negative Breast Cancer (ER-/PR-/HER2-)With BRCA1/2 Mutations

135 enrolled 14 charts

Phase 2 Active not recruiting

Breast Neoplasms

NCT06531447 2024-08-01

First-line Gemcitabine Plus Cisplatin in Locally Advanced (IIIC Stage) Breast Cancer Patients

200 enrolled

Phase 2 Not yet recruiting

Fibrosis Of Extraocular Muscles, Congenital, 3A, with or without Extraocular Involvement, Breast Neoplasms

NCT06510465 2024-07-19

NeoURANIA

143 enrolled

Breast Neoplasms

NCT04303988 2024-07-18

A Phase II Study of Triple-negative Breast Cancer Brain Metastases.

Phase 2 Recruiting

35 enrolled

Breast Neoplasms

NCT04265274 2023-10-06

Vinorelbine, Cisplatin, Disulfiram and Copper in CTC_EMT Positive Refractory Metastatic Breast Cancer.

Phase 2 Withdrawn

Breast Neoplasms

NCT03193853 2023-08-07

TAK-228 and TAK-117 Followed by Cisplatin and Nab Paclitaxel for Metastatic Triple Negative Breast Cancer

12 enrolled 11 charts

Triple Negative Breast Neoplasms

NCT04848454 2022-10-18

Efficacy and Safety of Combinition of Camrelizumab in Second-line Neoadjuvant Chemotherapy and Adjuvant Therapy

30 enrolled

HER2-negative Breast Cancer

NCT02341911 2022-04-20

TNBC

150 enrolled

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT04192903 2022-04-20

Chidamide Combined With Cisplatin for Relapsed or Metastatic Triple-negative Breast Cancer

55 enrolled

Triple Negative Breast Neoplasms

NCT02499367 2022-03-22

TONIC

84 enrolled

Breast Neoplasms, Neoplasm Metastasis

NCT04159818 2022-03-22

TONIC-2

Phase 2 Recruiting

52 enrolled

Breast Neoplasms, Neoplasm Metastasis

NCT04389073 2022-02-25

Safety and Efficacy of Toripalimab in HER2- Metastatic Breast Cancer Patients Treated With Metronomic Vinorelbine

138 enrolled

Breast Neoplasms

NCT03012477 2021-11-23

CISPLATIN + AZD-1775 In Breast Cancer

34 enrolled 9 charts

Triple-negative Metastatic Breast Cancer

NCT04781725 2021-11-17

INVINCIBLE TRIAL: Intratumoral INT230-6 in Breast Cancer

90 enrolled

Pathologic Complete Response, Breast Neoplasms

NCT00580333 2021-05-26

Preoperative Cisplatin and Bevacizumab in ER-, PR-, HER2 Negative Breast Cancer

51 enrolled 7 charts

Breast Neoplasms

NCT02185352 2021-05-07

A-Plus

120 enrolled

BreastCNS

Brain Neoplasms, Breast Neoplasms

NCT04517292 2020-08-18

GEP

160 enrolled

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT01606748 2019-09-30

A Drug-Interaction Study of Necitumumab (IMC-11F8) in Combination With Gemcitabine-Cisplatin

35 enrolled 23 charts

BreastThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung

NCT03644589 2019-04-26

Effect of Pembrolizumab and Cisplatin on Metastatic, Locally Recurrent or Inoperable Triple-Negative Breast Cancer

Phase 2 Withdrawn

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT01910870 2018-05-18

Phase II Pilot Study Assessing Efficacy of a Cisplatin - Metronomic Cyclophosphamide Treatment in Patients With Metastatic Triple Negative Breast Cancer Resistant to Anthracyclines and Taxanes

Phase 2 Terminated

4 enrolled

Breast Neoplasms

NCT01091454 2018-05-08

Brostallicin and Cisplatin in Treating Patients With Metastatic Breast Cancer

48 enrolled 10 charts

Breast Neoplasms, Breast Neoplasms, Male, Triple Negative Breast Neoplasms

NCT00201760 2017-12-27

Gemcitabine/ Trastuzumab and Gemcitabine/ Cisplatin/ Trastuzumab in Patients With Metastatic Breast Cancer

10 enrolled 9 charts

Breast Neoplasms, Neoplasm Metastasis

NCT02365805 2017-03-13

BERNAQ

30 enrolled

Breast Neoplasms

NCT01167192 2016-12-30

Neoadjuvant Platinum-based Chemoradiation Therapy for Locally Advanced Triple Negative Breast Cancer

Phase 2 Terminated

10 enrolled 8 charts

Breast Neoplasms

NCT00148694 2016-08-31

Preoperative Cisplatin in Early Stage Breast Cancer

27 enrolled

Breast Neoplasms

NCT00002998 2016-07-13

Gemcitabine and Cisplatin in Treating Patients With Metastatic Breast Cancer

59 enrolled

Breast Neoplasms

NCT02544243 2015-09-09

Vinorelbine/Gemcitabine Versus Vinorelbine/Cisplatin in Metastatic Breast Cancer

200 enrolled

Breast Neoplasms

NCT00930930 2015-05-07

Cisplatin and Paclitaxel With or Without Everolimus in Treating Patients With Stage II or Stage III Breast Cancer

145 enrolled 10 charts

Breast Neoplasms, Breast Neoplasms, Male, Triple Negative Breast Neoplasms

NCT01069081 2015-03-06

Docetaxel and Cisplatin Chemotherapy With or Without High Dose Proton Pump Inhibitor in Metastatic Breast Cancer

94 enrolled

Breast Neoplasms, Neoplasm Metastasis

NCT01928680 2015-02-23

Phase II Study of Capecitabine and Cisplatin to Treat Metastatic Triple Negative Breast Cancer

33 enrolled 5 charts

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT00463788 2014-02-13

BALI-1

181 enrolled 15 charts

Breast Neoplasms, Neoplasm Metastasis, Neoplasms

NCT01281696 2013-10-16

Bevacizumab With Etoposide and Cisplatin in Breast Cancer Patients With Brain and/or Leptomeningeal Metastasis

40 enrolled

BreastCNS

Brain Neoplasms, Breast Neoplasms, Meningeal Carcinomatosis

NCT00004900 2013-05-30

Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Women With Metastatic Breast Cancer

Breast Neoplasms

NCT00004906 2013-05-30

Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Women With Metastatic Breast Cancer

Breast Neoplasms

NCT01149798 2012-08-07

A Combination of Abraxane and Cisplatin in Metastatic Breast Cancer

73 enrolled

Breast Neoplasms

NCT01611727 2012-07-12

Cisplatin

20 enrolled

Breast Neoplasms, Neoplasm Metastasis

NCT01483300 2012-01-24

Effectiveness and Toxicity of Gemcitabine/Lobaplatin Versus Gemcitabine/Cisplatin as Second-line Treatment in Metastatic Breast Cancer

80 enrolled

Breast Neoplasms

NCT00003269 2011-01-10

Amifostine Followed by High Dose Chemotherapy in Treating Patients With Hematologic Cancer or Solid Tumors